Myeloid derived suppressor cells potentiate virus-specific memory CD8+ T cell response
Copyright © 2023 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved..
How therapeutically administered myeloid derived suppressor cells (MDSCs) modulate differentiation of virus-specific CD8+ T cell was investigated. In vitro generated MDSCs from bone marrow precursors inhibited the expansion of stimulated CD8+ T cells but the effector cells in the recipients of MDSCs showed preferential memory transition during Influenza A virus (IAV) or an α- (Herpes Simplex Virus) as well as a γ- (murine herpesvirus 68) herpesvirus infection. Memory CD8+ T cells thus generated constituted a heterogenous population with a large fraction showing effector memory (CD62LloCCR7-) phenotype. Such cells could be efficiently recalled in the rechallenged animals and controlled the secondary infection better. Memory potentiating effects of MDSCs occurred irrespective of the clonality of the responding CD8+ T cells as well as the nature of infecting viruses. Compared to the MDSCs recipients, effector cells of MDSCs recipients showed higher expression of molecules known to drive cellular survival (IL-7R, Bcl2) and memory formation (Tcf7, Id3, eomesodermin). Therapeutically administered MDSCs not only mitigated the tissue damaging response during a resolving IAV infection but also promoted the differentiation of functional memory CD8+ T cells. Therefore, MDSCs therapy could be useful in managing virus-induced immunopathological reactions without compromising immunological memory.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Microbes and infection - 26(2024), 3 vom: 15. März, Seite 105277 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sarkar, Roman [VerfasserIn] |
---|
Links: |
---|
Themen: |
HSV1 |
---|
Anmerkungen: |
Date Completed 20.03.2024 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.micinf.2023.105277 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365945609 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365945609 | ||
003 | DE-627 | ||
005 | 20240320233805.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231227s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.micinf.2023.105277 |2 doi | |
028 | 5 | 2 | |a pubmed24n1337.xml |
035 | |a (DE-627)NLM365945609 | ||
035 | |a (NLM)38103861 | ||
035 | |a (PII)S1286-4579(23)00190-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sarkar, Roman |e verfasserin |4 aut | |
245 | 1 | 0 | |a Myeloid derived suppressor cells potentiate virus-specific memory CD8+ T cell response |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.03.2024 | ||
500 | |a Date Revised 20.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved. | ||
520 | |a How therapeutically administered myeloid derived suppressor cells (MDSCs) modulate differentiation of virus-specific CD8+ T cell was investigated. In vitro generated MDSCs from bone marrow precursors inhibited the expansion of stimulated CD8+ T cells but the effector cells in the recipients of MDSCs showed preferential memory transition during Influenza A virus (IAV) or an α- (Herpes Simplex Virus) as well as a γ- (murine herpesvirus 68) herpesvirus infection. Memory CD8+ T cells thus generated constituted a heterogenous population with a large fraction showing effector memory (CD62LloCCR7-) phenotype. Such cells could be efficiently recalled in the rechallenged animals and controlled the secondary infection better. Memory potentiating effects of MDSCs occurred irrespective of the clonality of the responding CD8+ T cells as well as the nature of infecting viruses. Compared to the MDSCs recipients, effector cells of MDSCs recipients showed higher expression of molecules known to drive cellular survival (IL-7R, Bcl2) and memory formation (Tcf7, Id3, eomesodermin). Therapeutically administered MDSCs not only mitigated the tissue damaging response during a resolving IAV infection but also promoted the differentiation of functional memory CD8+ T cells. Therefore, MDSCs therapy could be useful in managing virus-induced immunopathological reactions without compromising immunological memory | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HSV1 | |
650 | 4 | |a Immune memory | |
650 | 4 | |a Immunopathology | |
650 | 4 | |a Influenza A virus | |
650 | 4 | |a MHV-68 | |
650 | 4 | |a Myeloid derived suppressor cells | |
700 | 1 | |a Shaaz, Mohammad |e verfasserin |4 aut | |
700 | 1 | |a Sehrawat, Sharvan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Microbes and infection |d 1999 |g 26(2024), 3 vom: 15. März, Seite 105277 |w (DE-627)NLM105022780 |x 1769-714X |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2024 |g number:3 |g day:15 |g month:03 |g pages:105277 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.micinf.2023.105277 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2024 |e 3 |b 15 |c 03 |h 105277 |